secwatch.observer — SEC 8-K summary
======================================

Issuer:     CUMBERLAND PHARMACEUTICALS INC (CPIX)
CIK:        0001087294
Form:       8-K
Filed at:   2024-04-29T23:59:59+00:00
Accession:  0001628280-24-019053
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Cumberland Pharmaceuticals shareholders re-elect directors, ratify auditor at annual meeting
--------------------------------------------------------------------------------

- Martin S. Brown, Jr. re-elected as Class II director with 96.0% of votes in favor (8,544,756 for, 352,239 withheld).
- James R. Jones re-elected as Class II director with 94.5% of votes in favor (8,411,468 for, 485,527 withheld).
- Ratification of Carr, Riggs & Ingram LLC as auditor for FY2024 passed with 99.9% of votes in favor (11,189,440 for, 15,502 against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1087294/000162828024019053/0001628280-24-019053-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1087294/000162828024019053/cpix-20240429.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-019053

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer